A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis
2004; BMJ; Volume: 64; Issue: 3 Linguagem: Inglês
10.1136/ard.2004.025015
ISSN1468-2060
Autores Tópico(s)Spondyloarthritis Studies and Treatments
ResumoThe Disease Activity Score1 is widely used to quantify disease activity and gauge response to treatment. A rather complex calculation conceals the relative contribution of each measure to the composite score. The 28 joint version (DAS28) is used in the British Society for Rheumatology guidelines to determine response to anti-tumour necrosis factor α (anti-TNFα) treatment.2 A reduction in DAS28 of ⩾1.2 is considered significant improvement, as is a reduction in DAS28 score to <3.2. These figures are important, as under current guidelines clinicians are advised to discontinue anti-TNF treatment if either of these criteria is not achieved at 3 months. …
Referência(s)